According to a new study, unvaccinated people are a threat to the safety of those who are vaccinated against coronavirus (COVID-19). Researchers explored the effect of mixing between unvaccinated and vaccinated people to understand the dynamics of an infectious disease. When vaccinated and unvaccinated people were mixed, a substantial number of new infections would occur in the vaccinated people. Read details here: https://www.wionews.com/science/unvaccinated-people-pose-a-threat-to-those-inoculated-against-covid-19-study-473685

If you are unvaccinated for COVID, you are a threat to those who're jabbed

The co-founder of BionNTech&nbsp;on Wednesday said that testing of the&nbsp;<a href="https://www.wionews.com/topics/coronavirus">coronavirus </a>variant first found in India is underway and expressed confidence its <a href="https://www.wionews.com/topics/coronavirus-vaccine">vaccine </a>will work against the strain.&nbsp;

"We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident," Ugur Sahin, was quoted as saying by news agency AFP.&nbsp;

Watch |&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-indians-asked-to-mask-up-at-home-380631/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

The remarks came as the World Health Organization (WHO) on Tuesday said that the variant found in India could be a factor in the huge rise of infections in the country and has been found in more than a dozen nations.&nbsp;

It said the B.1.617 strain, first detected in India had as of Tuesday been found in more than 1,200 sequences added in the GISAID open-access database "from at least 17 countries".&nbsp;

Also read | <a href="https://www.wionews.com/world/world-has-failed-india-amid-record-surge-in-covid-19-cases-says-top-us-disease-expert-fauci-381019">World has failed India amid record surge in COVID-19 cases, says top US disease expert Fauci</a>

"Most sequences were uploaded from India, the United Kingdom, USA and Singapore," the WHO said.

The global health agency recently declared B.1.617 as a "variant of interest," but still did not include it in the list of "variant of concern".

The "variant of concern" means that the virus could be more transmissible, deadly or can kill the effects of the vaccine.&nbsp;

Meanwhile, the new wave of COVID-19 continues to bring a massive surge in infections and death toll in India as the fatality toll went pass 200,000 on Wednesday.&nbsp;

India for the last many days is seeing the maximum number of daily cases than any other nation with hospitals reaching their capacity and patients struggling to get emergency care, oxygen and essential drugs.&nbsp;

(With inputs from agencies)

&nbsp;

 
&nbsp;

The co-founder of BionNTech on Wednesday said that testing of the coronavirus variant first found in India is underway and expressed confidence its vaccine will work against the strain.

The co-founder of BionNTech on Wednesday said that testing of the coronavirus variant first found in India is underway and expressed confidence its vaccine will work against the strain. "We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident," Ugur Sahin, was quoted as saying by news agency AFP. Watch | The remarks came as the World Health Organization (WHO) on Tuesday said that the variant found in India could be a factor in the huge rise of infections in the country and has been found in more than a dozen nations. It said the B.1.617 strain, first detected in India had as of Tuesday been found in more than 1,200 sequences added in the GISAID open-access database "from at least 17 countries". Also read | World has failed India amid record surge in COVID-19 cases, says top US disease expert Fauci "Most sequences were uploaded from India, the United Kingdom, USA and Singapore," the WHO said. The global health agency recently declared B.1.617 as a "variant of interest," but still did not include it in the list of "variant of concern". The "variant of concern" means that the virus could be more transmissible, deadly or can kill the effects of the vaccine. Meanwhile, the new wave of COVID-19 continues to bring a massive surge in infections and death toll in India as the fatality toll went pass 200,000 on Wednesday. India for the last many days is seeing the maximum number of daily cases than any other nation with hospitals reaching their capacity and patients struggling to get emergency care, oxygen and essential drugs. (With inputs from agencies)

BioNTech founder 'confident' its Covid vaccine willl work against strain first found in India

A diplomatic row has broken out after the EU's top official claimed the UK had imposed a ban on the export of Covid vaccines.

UK, EU at loggerheads over Covid vaccine

AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.

Phase-3 trial of Oxford-AstraZeneca Covid-19 vaccine to begin in few days